NCT02289209 2025-03-06
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
University of Pittsburgh
Phase 2 Completed
University of Pittsburgh
Sun Yat-sen University
Danish Head and Neck Cancer Group